Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Tina D. Tailor"'
Autor:
Anjali Gupta, Chioma Omeogu, Jessica Y. Islam, Ashwini Joshi, Dongyu Zhang, Dejana Braithwaite, Shama D. Karanth, Tina D. Tailor, Jeffrey M. Clarke, Tomi Akinyemiju
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Socioeconomic and racial disparities exist in access to care among patients with non-small cell lung cancer (NSCLC) in the United States. Immunotherapy is a widely established treatment modality for patients with advanced-stage NSCLC (aNSCLC
Externí odkaz:
https://doaj.org/article/25160e5fe08d435db56e66ee21ba0a2b
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 8567-8580 (2023)
Abstract Background With early intervention, palliative care (PC) can improve quality of life and increase survival among advanced‐stage non‐small cell lung cancer (aNCSLC) patients. However, PC is often offered late in the cancer treatment cours
Externí odkaz:
https://doaj.org/article/8dafa100966442b29bfaa121435fcbc7
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Indeterminate pulmonary lesions (IPL) detected by CT pose a significant clinical challenge, frequently necessitating long-term surveillance or biopsy for diagnosis. In this pilot investigation, we performed whole exome sequencing (WES)
Externí odkaz:
https://doaj.org/article/e870736bdd01495ea400074938602925
Autor:
Tina D, Tailor, M Patricia, Rivera, Danielle D, Durham, Pasangi, Perera, Lindsay, Lane, Louise M, Henderson
Publikováno v:
Journal of the American College of Radiology. 19:945-953
The aim of this study was to determine the frequency, components of, and factors associated with shared decision-making (SDM) discussions according to electronic health record (EHR) documentation among individuals undergoing lung cancer screening (LC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817b3ac0166ca849ab7517fd77d5b30a
https://doi.org/10.1016/j.jacr.2022.03.005
https://doi.org/10.1016/j.jacr.2022.03.005
Autor:
Ilana F. Gareen, Roee Gutman, JoRean Sicks, Tina D. Tailor, Richard M. Hoffman, Amal N. Trivedi, Efren Flores, Ellen Underwood, Jerson Cochancela, Caroline Chiles
Publikováno v:
JAMA Internal Medicine.
ImportanceLow-dose computed tomography (LDCT) lung screening has been shown to reduce lung cancer mortality. Significant incidental findings (SIFs) have been widely reported in patients undergoing LDCT lung screening. However, the exact nature of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f796ac5aedb639314e75f22656f4612e
https://doi.org/10.1001/jamainternmed.2023.1116
https://doi.org/10.1001/jamainternmed.2023.1116
Publikováno v:
Thoracic Surgery Clinics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3b35007b988ae647b37dade571f3f7a
https://doi.org/10.1016/j.thorsurg.2023.04.001
https://doi.org/10.1016/j.thorsurg.2023.04.001
Publikováno v:
North Carolina Medical Journal. 82:321-326
BACKGROUND Low-dose chest CT (LDCT) is the only effective screening test for lung cancer. Annual lung cancer screening (LCS) is recommended by the US Preventive Services Task Force (USPSTF) for individuals at high risk for primary lung neoplasm.METHO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8361232f86211f634066a20c80ddda5
https://doi.org/10.18043/ncm.82.5.321
https://doi.org/10.18043/ncm.82.5.321
Publikováno v:
Cancer medicineREFERENCES.
With early intervention, palliative care (PC) can improve quality of life and increase survival among advanced-stage non-small cell lung cancer (aNCSLC) patients. However, PC is often offered late in the cancer treatment course and is underused. We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e6c9a4b6146629ff9ae58e34d1df9e
https://pubmed.ncbi.nlm.nih.gov/36533434
https://pubmed.ncbi.nlm.nih.gov/36533434
Publikováno v:
Journal of the American College of Radiology : JACR.
Adherence to lung cancer screening (LCS) is central to effective screening. The authors evaluated the likelihood of repeat annual LCS in a national commercially insured population and associations with individual characteristics, insurance characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ffb313d79e124833566987927ff9f4
https://pubmed.ncbi.nlm.nih.gov/36436778
https://pubmed.ncbi.nlm.nih.gov/36436778
Autor:
Michael B. Atkins, Dongyu Zhang, Tomi Akinyemiju, Tina D. Tailor, Chul Kim, Dejana Braithwaite
Publikováno v:
J Immunother
In patients with metastatic non-small cell lung cancer (mNSCLC), the extent to which immunotherapy utilization rate varies by comorbidities is unclear. Using the National Cancer Database (NCDB) from 2015 to 2016, we assessed the association between l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4e33b2e9488f47cf662f7da83765ff
https://doi.org/10.1097/cji.0000000000000366
https://doi.org/10.1097/cji.0000000000000366